Over the past 3 months, 6 analysts have published their opinion on Synaptics (NASDAQ:SYNA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
SAN JOSE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (NASDAQ:SYNA) today announced that the evaluation kit (EVK) for its Katana ultra-low-power Edge AI SoC platform is now
Gainers
AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Gainers
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
Rosenblatt analyst Kevin Cassidy highlighted some key takeaways from last week's semiconductor earnings.
Last week's earnings reports made it clear that companies exposed to the higher-end of markets saw their earnings holding up better.